Dr. Kirstie Keller is a member of the Center for Strategic Philanthropy’s biomedical science team, currently leading the center’s work on single ventricle heart defects, nonprofit drug development and venture philanthropy, and Alzheimer’s disease. With over ten years of experience in life sciences, she brings a unique set of skills and expertise, combining experience conducting scientific research at its highest level with a deep understanding of business conducted in a matrixed environment.
During her time as a consultant, she led research and business teams in the design, development, and execution of highly complex, data-driven projects. Dr. Keller received her BSc in biology from Gonzaga University and her doctoral degree in biology from Johns Hopkins University. Additionally, she completed a post-doctoral fellowship at the Johns Hopkins School of Medicine. Her thesis work focused on cancer cell metabolism, where she developed a novel method of identifying protein-metabolite interactions. In her post-doctoral work, she studied the unique regulatory pathways of pathogenic bacteria.